Chen Zhongping
陈忠平
Areas of Expertise
Professional Biography
Dr. Chen Zhongping is Founder & Chairman, Neurosurgery/Neuro-oncology at Sun Yat-sen University Cancer Center, Guangzhou. Medical degree and neurosurgery training (China).
Education & Training
- Medical degree and neurosurgery training (China)
- 44 years of neurosurgery and oncology experience
Awards & Certifications
- Francis McNaughton Memorial Prize, Canadian Neurological Society (1998)
- WHO Prize for Chinese Young Professional in Mental Health & Neuroscience (1993)
Leadership & Board Memberships
- Founder & Chairman, Neurosurgery/Neuro-oncology Department, SYSUCC
- Principal investigator, KOMET study (Lancet 2025): international Phase 3 trial on selumetinib for NF1
- Principal investigator, temozolomide ± interferon alfa RCT (JAMA Network Open)
Pioneering Contributions
First in the world to report vasculogenic mimicry (VM) in glioma — discovering that brain tumors create their own blood supply independent of conventional angiogenesis; cited in Lancet 2025
Led KOMET (Lancet 2025) — international Phase 3 trial on selumetinib for NF1
Led first RCT on adjuvant temozolomide with interferon alfa for high-grade glioma
International Patient Services
Full support for your journey to China
Medipath provides comprehensive support for international patients. Services include full English-speaking medical consultations, dedicated medical translation staff, and specialized assistance with medical visa applications to ensure a seamless healthcare journey.
English Consultations
Full English-speaking medical appointments
Medical Translation
Dedicated translation for all documentation
Visa Assistance
Medical visa application support